Guangdong Taienkang Pharmaceutical Co., Ltd. (SHE:301263)
China · Delayed Price · Currency is CNY 27.08
+0.80 (3.04%)
May 19, 2026, 4:00 PM EDT
SHE:301263 Market Cap
SHE:301263 has a market cap or net worth of 11.47 billion as of May 19, 2026. Its market cap has increased by 36.35% in one year.
Market Cap
11.47B
Enterprise Value
11.32B
Revenue
674.49M
Ranking
n/a
PE Ratio
492.44
Stock Price
27.08
Market Cap Chart
Since March 29, 2022, SHE:301263's market cap has increased from 8.26B to 11.47B, an increase of 38.86%. That is a compound annual growth rate of 8.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2026 | 11.47B | -6.59% |
| Dec 31, 2025 | 12.28B | 93.40% |
| Dec 31, 2024 | 6.35B | -8.63% |
| Dec 29, 2023 | 6.95B | -9.56% |
| Dec 30, 2022 | 7.68B | -6.98% |
| Mar 29, 2022 | 8.26B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zhejiang Hisun Pharmaceutical | 12.61B |
| Henan Lingrui Pharmaceutical | 12.42B |
| Shanghai Shyndec Pharmaceutical | 12.34B |
| Ningbo Menovo Pharmaceutical | 12.02B |
| Zhejiang Jiuzhou Pharmaceutical | 11.65B |
| Zhejiang Jingxin Pharmaceutical | 11.54B |
| Wanbangde Pharmaceutical Holding Group | 10.99B |
| Zhejiang CONBA Pharmaceutical | 10.86B |